{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:58:17Z","timestamp":1790546297743,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070265"],"award-info":[{"award-number":["82070265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970347"],"award-info":[{"award-number":["81970347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37227","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T01:20:19Z","timestamp":1724980819000},"page":"e37227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-2984","authenticated-orcid":false,"given":"Tengfei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guopin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-2192","authenticated-orcid":false,"given":"Fan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2024.e37227_bib1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Drygin","year":"2011","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37227_bib2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for cancer therapeutics","volume":"3","author":"Haddach","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37227_bib3","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1096\/fj.14-254680","article-title":"Connecting the nucleolus to the cell cycle and human disease","volume":"28","author":"Tsai","year":"2014","journal-title":"Faseb j."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37227_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molcel.2010.09.024","article-title":"The nucleolus under stress","volume":"40","author":"Boulon","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.heliyon.2024.e37227_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15698\/cst2018.06.139","article-title":"Nucleolar Stress: hallmarks, sensing mechanism and diseases","volume":"2","author":"Yang","year":"2018","journal-title":"Cell Stress"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37227_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc3496","article-title":"Dysregulation of the basal RNA polymerase transcription apparatus in cancer","volume":"13","author":"Bywater","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37227_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/cells9020266","article-title":"Targeting the RNA polymerase I transcription for cancer therapy comes of age","volume":"9","author":"Ferreira","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37227_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","article-title":"First-in-Human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study","volume":"9","author":"Khot","year":"2019","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37227_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/ATVBAHA.116.308401","article-title":"Therapeutic targeting of RNA polymerase I with the small-molecule CX-5461 for prevention of arterial injury-induced neointimal hyperplasia","volume":"37","author":"Ye","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37227_bib10","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/TP.0000000000002372","article-title":"The selective RNA polymerase I inhibitor CX-5461 mitigates neointimal remodeling in a modified model of rat aortic transplantation","volume":"102","author":"Dai","year":"2018","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37227_bib11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/bph.15385","article-title":"Therapeutic efficacy of the novel selective RNA polymerase I inhibitor CX-5461 on pulmonary arterial hypertension and associated vascular remodeling","volume":"178","author":"Xu","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e37227_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174303","article-title":"Anti-fibrotic effects of p53 activation induced by RNA polymerase I inhibitor in primary cardiac fibroblasts","volume":"907","author":"Pang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37227_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2009.09.024","article-title":"Signaling to p53: ribosomal proteins find their way","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"issue":"31","key":"10.1016\/j.heliyon.2024.e37227_bib14","doi-asserted-by":"crossref","first-page":"49800","DOI":"10.18632\/oncotarget.10452","article-title":"Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM\/ATR signaling","volume":"7","author":"Quin","year":"2016","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.heliyon.2024.e37227_bib15","doi-asserted-by":"crossref","first-page":"18094","DOI":"10.18632\/oncotarget.4093","article-title":"rRNA synthesis inhibitor, CX-5461, activates ATM\/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis","volume":"6","author":"Negi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e37227_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2017.03.050","article-title":"DNA damage-dependent mechanisms of ageing and disease in the macro- and microvasculature","volume":"816","author":"Shah","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e37227_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pharmthera.2014.12.001","article-title":"ATM and ATR as therapeutic targets in cancer","volume":"149","author":"Weber","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37227_bib18","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/s41467-020-16393-4","article-title":"CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer","volume":"11","author":"Sanij","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37227_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaa032","article-title":"The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability","volume":"2","author":"Mars","year":"2020","journal-title":"NAR Cancer"},{"key":"10.1016\/j.heliyon.2024.e37227_bib20","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37227_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20112100","article-title":"Replication fork dynamics and the DNA damage response","volume":"443","author":"Jones","year":"2012","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37227_bib22","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.1921649117","article-title":"The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning","volume":"117","author":"Bruno","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37227_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol Cell"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e37227_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10616-009-9236-6","article-title":"Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas","volume":"61","author":"Xu","year":"2009","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37227_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12900","article-title":"Inhibition of nucleolar stress response by Sirt1: a potential mechanism of acetylation-independent regulation of p53 accumulation","volume":"18","author":"Bi","year":"2019","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37227_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.onc.1209828","article-title":"ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation","volume":"26","author":"Wu","year":"2007","journal-title":"Oncogene"},{"issue":"31","key":"10.1016\/j.heliyon.2024.e37227_bib27","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1038\/sj.onc.1205614","article-title":"Association of p53 and MSH2 with recombinative repair complexes during S phase","volume":"21","author":"Zink","year":"2002","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37227_bib28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/humu.21101","article-title":"Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant","volume":"30","author":"Li","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.heliyon.2024.e37227_bib29","first-page":"1","article-title":"Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair","volume":"769","author":"Gustafsson","year":"2014","journal-title":"Mutat. Res."},{"key":"10.1016\/j.heliyon.2024.e37227_bib30","article-title":"Immunofluorescence imaging of DNA damage and repair foci in human colon cancer cells","volume":"160","author":"Maliszewska-Olejniczak","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.heliyon.2024.e37227_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcdb.2020.08.010","article-title":"RAD51: beyond the break","volume":"113","author":"Wassing","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e37227_bib32","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.febslet.2011.05.053","article-title":"Dynamic regulation of PCNA ubiquitylation\/deubiquitylation","volume":"585","author":"Fox","year":"2011","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37227_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-021-02124-0","article-title":"Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models","volume":"40","author":"Coulson-Gilmer","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37227_bib34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/nar\/gkt957","article-title":"Detection of G-quadruplex DNA in mammalian cells","volume":"42","author":"Henderson","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37227_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bbrc.2004.08.150","article-title":"Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase","volume":"323","author":"Lemarteleur","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37227_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.molmed.2013.07.005","article-title":"The nucleolus: an emerging target for cancer therapy","volume":"19","author":"Hein","year":"2013","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37227_bib37","first-page":"189","article-title":"An oncogenic target of pre-ribosomal RNA synthesis","volume":"1866","author":"Jin","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heliyon.2024.e37227_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106120","article-title":"CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5","volume":"177","author":"Pan","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37227_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e37227_bib40","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1038\/onc.2015.427","article-title":"RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress","volume":"35","author":"Kanu","year":"2016","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e37227_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10577-018-9599-7","article-title":"Ribosomal DNA instability and genome adaptability","volume":"27","author":"Salim","year":"2019","journal-title":"Chromosome Res."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e37227_bib42","doi-asserted-by":"crossref","first-page":"22174","DOI":"10.18632\/aging.104094","article-title":"Nucleolar stress induces a senescence-like phenotype in smooth muscle cells and promotes development of vascular degeneration","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37227_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5483\/BMBRep.2019.52.2.213","article-title":"High expression of RAD51 promotes DNA damage repair and survival in KRAS-mutant lung cancer cells","volume":"52","author":"Hu","year":"2019","journal-title":"BMB Rep"},{"key":"10.1016\/j.heliyon.2024.e37227_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101604","article-title":"Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells","volume":"36","author":"Xu","year":"2020","journal-title":"Redox Biol."},{"issue":"Supplement 1","key":"10.1016\/j.heliyon.2024.e37227_bib45","first-page":"4627","article-title":"A small molecule RAD51 inhibitor preferentially affects cells expressing high cytidine deaminase activity","volume":"130","author":"Mills","year":"2017","journal-title":"Blood"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:33:14Z","timestamp":1790544794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024132586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024132586"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37227","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37227"}}